1080dkk
9,6 %
Date:2025-02-21Time:17:20:00Latest report:Q3-2024List:First NorthTicker:VIRO
Market Cap:84 mdkkEnterprise Value:81 mdkkNet Sales:4,20 mdkkEarnings:-13,2 mdkkEmployees:0ISIN:DK0061030574

Ratios

10-year key figure history for ViroGates turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ViroGates with index and moving average MA50 and MA200.

Stockprice:10,80
MA50:12,35
MA200:8,88
Price/MA200:21,7 %
RSI (14):46,2
Price/MA50:-12,5 %

Description

ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

Medical Equipment